|
ATCC
ab 9 Ab 9, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ab 9/product/ATCC Average 93 stars, based on 1 article reviews
ab 9 - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
New England Biolabs
streptococcus pneumoniae α2 3 neuraminidase s Streptococcus Pneumoniae α2 3 Neuraminidase S, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/streptococcus pneumoniae α2 3 neuraminidase s/product/New England Biolabs Average 95 stars, based on 1 article reviews
streptococcus pneumoniae α2 3 neuraminidase s - by Bioz Stars,
2026-05
95/100 stars
|
Buy from Supplier |
|
Bio-Rad
anti s pneumoniae rabbit polyclonal igg antibody ![]() Anti S Pneumoniae Rabbit Polyclonal Igg Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti s pneumoniae rabbit polyclonal igg antibody/product/Bio-Rad Average 85 stars, based on 1 article reviews
anti s pneumoniae rabbit polyclonal igg antibody - by Bioz Stars,
2026-05
85/100 stars
|
Buy from Supplier |
|
Novus Biologicals
nb100 64570 ![]() Nb100 64570, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/nb100 64570/product/Novus Biologicals Average 93 stars, based on 1 article reviews
nb100 64570 - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
anti s pneumoniae ![]() Anti S Pneumoniae, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti s pneumoniae/product/Novus Biologicals Average 93 stars, based on 1 article reviews
anti s pneumoniae - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
s pneumoniae ![]() S Pneumoniae, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/s pneumoniae/product/Novus Biologicals Average 93 stars, based on 1 article reviews
s pneumoniae - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
ATCC
streptococcus pneumoniae ![]() Streptococcus Pneumoniae, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/streptococcus pneumoniae/product/ATCC Average 97 stars, based on 1 article reviews
streptococcus pneumoniae - by Bioz Stars,
2026-05
97/100 stars
|
Buy from Supplier |
|
ATCC
strain atcc 6303 ![]() Strain Atcc 6303, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/strain atcc 6303/product/ATCC Average 97 stars, based on 1 article reviews
strain atcc 6303 - by Bioz Stars,
2026-05
97/100 stars
|
Buy from Supplier |
Journal: Communications Chemistry
Article Title: Creating unimolecular multivalent diversity in protein conjugates via the Passerini multicomponent bioconjugation with isocyanoproteins
doi: 10.1038/s42004-025-01827-1
Figure Lengend Snippet: Passerini bioconjugation for the assembly of multivalent glycoconjugates incorporating bacterial polysaccharide antigens . A Repeating unit of the pneumococcal serotype 14 (Pn14) and the meningococcal serogroup C (MenC) capsular polysaccharides (CPs). B SE-HPLC traces (TSK 5000 PW column) of the natural, fragmented and—for CPs Pn14—oxidized polysaccharides. C Schematic representation of the structures of the multivalent BSA-MenC-Pn14 glycoconjugates produced by the Passerini bioconjugation with isocyanoproteins. D Antigenicity evaluation by Dot blot assays of glycoconjugates 23, 24, 25 and 26 in comparison with isocyano-BSAs and modified CPs, using reference antibodies against BSA, S. pneumoniae and N. meningitidis . Native BSA and the natural CPs antigens were used as positive controls.
Article Snippet: Next, the membrane was incubated with the primary antibodies: anti-BSA rabbit polyclonal IgG antibody (1:1000, Invitrogen Ref A11133, Lot 2206803),
Techniques: Produced, Dot Blot, Comparison, Modification
Journal: Frontiers in Pharmacology
Article Title: Respiratory virus-induced bacterial dysregulation in pediatric airway tissue and the dual actions of Echinacea in reducing complications
doi: 10.3389/fphar.2025.1579551
Figure Lengend Snippet: Efficacy of Echinaforce in reducing RSV-induced S. pneumoniae adhesion in pediatric EpiAirway tissue. (A) EpiAirway tissues cultured in an air-liquid interface (ALI) were stained with anti- S. pneumoniae antibody (green) and DAPI for nuclei, visualized at ×20 magnification. Representative images are shown for the following conditions: (A) Vehicle Control + S. pneumoniae , (B) RSV + S. pneumoniae , (C) RSV + EF 1:200 + S. pneumoniae , and (D) RSV + EF 1:400 + S. pneumoniae . (B) Bar chart shows S. pneumoniae adhesion under different conditions: uninfected tissue (infected with S. pneumoniae but not RSV), RSV-infected, and RSV-infected tissues treated with Echinaforce ® (EF) at 1:200 and 1:400 dilutions. Data represent ALI-cultured EpiAirway tissues, with statistical significance indicated (* p < 0.05; ** p < 0.01) ns = not significant.
Article Snippet: After permeabilization with 0.3% Triton X-100 and blocking with 3% BSA in PBST, sections were incubated overnight at 4°C with the primary antibodies:
Techniques: Cell Culture, Staining, Control, Infection
Journal: Frontiers in Pharmacology
Article Title: Respiratory virus-induced bacterial dysregulation in pediatric airway tissue and the dual actions of Echinacea in reducing complications
doi: 10.3389/fphar.2025.1579551
Figure Lengend Snippet: Blocking ICAM-1 and PAFr reduces S. pneumoniae adhesion to virus-infected NHBE cells. Anti-ICAM-1 and anti-PAFr antibodies significantly reduced S. pneumoniae adhesion in (A) RSV- and (B) HPIV3-infected NHBE cells, rather than with PV14 infection (C) . Results are expressed as mean values ±SD from three independent experiments Statistical significance: p < 0.01 (**), p < 0.0001 (****), “ns” indicates no significance.
Article Snippet: After permeabilization with 0.3% Triton X-100 and blocking with 3% BSA in PBST, sections were incubated overnight at 4°C with the primary antibodies:
Techniques: Blocking Assay, Virus, Infection
Journal: Frontiers in Pharmacology
Article Title: Respiratory virus-induced bacterial dysregulation in pediatric airway tissue and the dual actions of Echinacea in reducing complications
doi: 10.3389/fphar.2025.1579551
Figure Lengend Snippet: Efficacy of Echinaforce in reducing RSV-induced S. pneumoniae adhesion in pediatric EpiAirway tissue. (A) EpiAirway tissues cultured in an air-liquid interface (ALI) were stained with anti- S. pneumoniae antibody (green) and DAPI for nuclei, visualized at ×20 magnification. Representative images are shown for the following conditions: (A) Vehicle Control + S. pneumoniae , (B) RSV + S. pneumoniae , (C) RSV + EF 1:200 + S. pneumoniae , and (D) RSV + EF 1:400 + S. pneumoniae . (B) Bar chart shows S. pneumoniae adhesion under different conditions: uninfected tissue (infected with S. pneumoniae but not RSV), RSV-infected, and RSV-infected tissues treated with Echinaforce ® (EF) at 1:200 and 1:400 dilutions. Data represent ALI-cultured EpiAirway tissues, with statistical significance indicated (* p < 0.05; ** p < 0.01) ns = not significant.
Article Snippet: After 2 h at 37°C, unbound bacteria were removed by five DPBS washes, and the tissues were fixed with 10% formalin for 45 min. Adherent bacteria were quantified using specific primary antibodies: NB100-64570 for
Techniques: Cell Culture, Staining, Control, Infection
Journal: Frontiers in Pharmacology
Article Title: Respiratory virus-induced bacterial dysregulation in pediatric airway tissue and the dual actions of Echinacea in reducing complications
doi: 10.3389/fphar.2025.1579551
Figure Lengend Snippet: Blocking ICAM-1 and PAFr reduces S. pneumoniae adhesion to virus-infected NHBE cells. Anti-ICAM-1 and anti-PAFr antibodies significantly reduced S. pneumoniae adhesion in (A) RSV- and (B) HPIV3-infected NHBE cells, rather than with PV14 infection (C) . Results are expressed as mean values ±SD from three independent experiments Statistical significance: p < 0.01 (**), p < 0.0001 (****), “ns” indicates no significance.
Article Snippet: After 2 h at 37°C, unbound bacteria were removed by five DPBS washes, and the tissues were fixed with 10% formalin for 45 min. Adherent bacteria were quantified using specific primary antibodies: NB100-64570 for
Techniques: Blocking Assay, Virus, Infection